Radiation Oncology Treatments
We apply advanced radiotherapy technology to target the tumor with accuracy measured in millimeters. We use 4-dimensional CT simulation with a monitoring system that can gate the beam delivery with the patient's breathing cycle to determine the exact location, shape and size of the tumor to be treated and minimize exposure to healthy tissue.
Organ Motion Management
- Real-Time Position Management (RPM) Respiratory Gating System
- Deep Inspiration Breath Hold (DIBH) Technique
- Calypso Beacon System (GPS system in the tumor)
- Optical Surface Monitoring System (OSMS) for motion management
External Beam Radiation Therapy
- 3D Conformal Radiation Therapy (3D-CRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Prone Breast Irradiation
- Accelerated Partial Breast Irradiation (APBI)
- 4D CT Simulator with breathing control
- Sophisticated Eclipse Treatment Planning System driven by artificial intelligence
- Real-time Image Verifying System, which visualizes the radiation beam, reaching to the tumor
Radiosurgery/SBRT
- Stereotactic Radiosurgery (SRS)
- Stereotactic Radiotherapy (SRT)
- Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Ablative Radiotherapy (SABR)
- Hypofractionated SBRT
- Intensity-Modulated Radiosurgery
The New Line of Defense in the Fight against Cancer
Radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are noninvasive treatments that use 3D imaging to precisely target small benign or malignant tumors with minimal impact on the surrounding healthy tissue. It can be a sole modality of treatment or used together with surgery and chemotherapy.
Stereotactic radiosurgery of the brain and spine is typically completed in a single session. Like other forms of radiation, stereotactic radiosurgery works by damaging the DNA of the targeted cells. The affected cells then lose the ability to reproduce, which causes tumors to shrink. Body radiosurgery is used to treat lung, liver, adrenal and other soft tissue tumors, and treatment typically involves multiple (three to five) sessions.
Examples of benign or malignant conditions treated with radiosurgery/SBRT.
State-of-the-Art Theranostic Cancer Treatments
We are the only approved clinical center on the East End of Long Island eligible to administer Pluvicto™, the radiopharmaceutical that treats progressing metastatic castration-resistant prostate cancer, called mCRPC, which shows on a PSMA-PET scan. Pluvicto is the FIRST and ONLY radioligand therapy. This precision cancer treatment smartly targets the PSMA-positive cancer cells, and is a step forward adding more therapeutic options for prostate cancer. For a clinical evaluation to determine treatment eligibility, call (631) 638-7400 Option 4.